Multimodality and Multidisciplinary treatment
Multimodality & Multi-disciplinary treatment is implemented at every stage of cancer management, including screening, early detection, diagnosis, and ultimately, multimodal treatment. Diagnosis is performed carefully and standardized using advanced blood tests and diagnostic imaging techniques such as digital mammography, CT 640-slice, 3 Tesla-MRI, PET/CT, SPECT/CT, pathology, molecular biology, etc. All diagnostic methods adhere to the standards of the most reputable international professional associations, such as the College of American Pathologists (CAP) and the American College of Radiology (ACR) for imaging diagnosis.
Before treatment, patients go through a Tumor Board composed of experts in surgical oncology, medical oncology, diagnostic imaging, pathology, stem cells and genetic technology, functional rehabilitation, psychology, nutrition, pain management, palliative care, and other relevant specialties as needed. This ensures accurate diagnosis, increases effectiveness, and minimizes adverse effects for patients. All multi-disciplinary treatment decisions are based on standard guidelines from leading global professional associations such as NCCN, ASTRO, ESMO, and ASCO.